Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Cardiac side-effects of cancer chemotherapy
2010
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
2012 Standout
ROS in cancer therapy: the bright side of the moon
2020 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
2011
TFOS DEWS II pathophysiology report
2017 Standout
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
2011
Lack of lymphocytes impairs macrophage polarization and angiogenesis in diabetic wound healing
2020
Hallmarks of Cellular Senescence
2018 Standout
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
2011
Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage
2010
The role of cellular senescence in cardiac disease: basic biology and clinical relevance
2021
Mechanisms and management of doxorubicin cardiotoxicity
2011
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Effects of chemotherapy during pregnancy on the maternal and fetal heart
2012
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
2012
Epigenetic Regulatory Mechanisms Induced by Resveratrol
2017
Upregulation of SIRT1 contributes to the cardioprotective effect of Rutin against myocardial ischemia-reperfusion injury in rats
2018
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Small molecule compounds that induce cellular senescence
2016
Nanotherapy and Reactive Oxygen Species (ROS) in Cancer: A Novel Perspective
2018
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
2011
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Immunology of Acute and Chronic Wound Healing
2021 Standout
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Donato Cappetta being referenced
SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
2015
VEGFR endocytosis regulates the angiogenesis in a mouse model of hindlimb ischemia
2019
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells
2013
SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells
2015
Doxorubicin targets multiple players: A new view of an old problem
2017
Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
2009
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
2016